Title:
COMPOUNDS AND THEIR USES AS CD38 INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2022/228496
Kind Code:
A1
Abstract:
Provided are compounds of Formula I which can be used as CD38 inhibitors; methods for the production of the compounds; pharmaceutical compositions comprising the compounds; as well as uses and methods for treating a disease mediated by CD38 by administering the compounds.
Inventors:
XI JIANBEI (CN)
FAN GUOHUANG (CN)
WANG JIANFEI (CN)
FONG KIN CHIU (CN)
FAN GUOHUANG (CN)
WANG JIANFEI (CN)
FONG KIN CHIU (CN)
Application Number:
PCT/CN2022/089735
Publication Date:
November 03, 2022
Filing Date:
April 28, 2022
Export Citation:
Assignee:
NANJING IMMUNOPHAGE BIOTECH CO LTD (CN)
International Classes:
C07D401/04; A61K31/166; A61P35/00; C07D401/14; C07D403/04; C07D403/14
Domestic Patent References:
| WO2019227059A1 | 2019-11-28 | |||
| WO2016087975A1 | 2016-06-09 |
Foreign References:
| CN112279837A | 2021-01-29 |
Other References:
DATABASE REGISTRY 16 September 2010 (2010-09-16), XP055981902, retrieved from STN Database accession no. RN:1241723-70-5，1241721-76-5
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF:
Previous Patent: PREPARATION METHOD FOR ANTIBODY-DRUG CONJUGATE, AND APPLICATION
Next Patent: USE OF MEDICAMENT IN TREATMENT OF TUMOR DISEASE
Next Patent: USE OF MEDICAMENT IN TREATMENT OF TUMOR DISEASE